IP Verse

Tad Pharma competitive analysis

Loading summary...

Explore patent oppositions filed by Tad Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3578175	Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound	AMGEN	Aug 30, 2023
EP3260117	Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound	AMGEN	Mar 8, 2021

Explore the latest publications and patents granted to Tad Pharma, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Tad Pharma, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Tad Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
TAD PHARMA	2	-	-	-
AMGEN	8	138	8	11